GlassScriptPhysician profile
Joseph Rosen
NPI 1225002413
$819.03
in general payments reported to CMS, 2019-2025
25 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.27 · 2020: $30.11 · 2021: $74.84 · 2022: $376 · 2023: $114 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $120.76 | 2025 | Monoferric |
| Celgene Corporation | $100.26 | 2022 | |
| Emd Serono, INC. | $54.66 | 2021-2023 | Bavencio |
| Janssen Biotech, INC. | $53.11 | 2020-2021 | |
| Genzyme Corporation | $49.44 | 2022-2023 | |
| Kite Pharma, INC. | $44.30 | 2022 | |
| Abbvie INC. | $40.66 | 2022-2023 | Lupron Depot |
| Gilead Sciences, INC. | $33.54 | 2021-2022 | |
| Seagen INC. | $32.40 | 2022 | |
| Pfizer INC. | $31.91 | 2022 | |
| Daiichi Sankyo INC. | $29.02 | 2025 | Enhertu |
| Puma Biotechnology, INC. | $27.98 | 2025 | |
| Mirati Therapeutics, INC. | $25.47 | 2023 | Krazati |
| Novartis Pharmaceuticals Corporation | $22.74 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.38 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $19.55 | 2025 | |
| Amgen INC. | $17.06 | 2022 | |
| Kyowa Kirin, INC. | $16.50 | 2022 | |
| Glaxosmithkline, LLC. | $15.82 | 2025 | Ojjaara |
| Beigene USA, INC. | $14.09 | 2022 | |
| Astellas Pharma US INC | $13.17 | 2022 | |
| Eusa Pharma (US) LLC | $12.28 | 2020 | |
| Eisai INC. | $11.66 | 2022 | |
| Horizon Therapeutics Plc | $11.27 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.